144 related articles for article (PubMed ID: 16317586)
1. Genotypic and allelic frequencies of SULT1A1 polymorphisms in women receiving adjuvant tamoxifen therapy.
Grabinski JL; Smith LS; Chisholm GB; Drengler R; Rodriguez GI; Lang AS; Kalter SP; Garner AM; Fichtel LM; Hollsten J; Pollock BH; Kuhn JG
Breast Cancer Res Treat; 2006 Jan; 95(1):13-6. PubMed ID: 16317586
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer.
Wegman P; Elingarami S; Carstensen J; Stål O; Nordenskjöld B; Wingren S
Breast Cancer Res; 2007; 9(1):R7. PubMed ID: 17244352
[TBL] [Abstract][Full Text] [Related]
3. Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
Seth P; Lunetta KL; Bell DW; Gray H; Nasser SM; Rhei E; Kaelin CM; Iglehart DJ; Marks JR; Garber JE; Haber DA; Polyak K
Cancer Res; 2000 Dec; 60(24):6859-63. PubMed ID: 11156380
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients.
Nowell SA; Ahn J; Rae JM; Scheys JO; Trovato A; Sweeney C; MacLeod SL; Kadlubar FF; Ambrosone CB
Breast Cancer Res Treat; 2005 Jun; 91(3):249-58. PubMed ID: 15952058
[TBL] [Abstract][Full Text] [Related]
5. Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients.
Wegman P; Vainikka L; Stål O; Nordenskjöld B; Skoog L; Rutqvist LE; Wingren S
Breast Cancer Res; 2005; 7(3):R284-90. PubMed ID: 15987423
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of CYP2D6 polymorphisms and tamoxifen in women with breast cancer.
Gaston C; Kolesar J
Clin Adv Hematol Oncol; 2008 Nov; 6(11):825-33. PubMed ID: 19194367
[TBL] [Abstract][Full Text] [Related]
7. Impact of polymorphism in sulfotransferase gene on the risk of lung cancer.
Pachouri SS; Sobti RC; Kaur P; Singh J; Gupta SK
Cancer Genet Cytogenet; 2006 Nov; 171(1):39-43. PubMed ID: 17074589
[TBL] [Abstract][Full Text] [Related]
8. Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy.
Nowell S; Sweeney C; Winters M; Stone A; Lang NP; Hutchins LF; Kadlubar FF; Ambrosone CB
J Natl Cancer Inst; 2002 Nov; 94(21):1635-40. PubMed ID: 12419790
[TBL] [Abstract][Full Text] [Related]
9. Sulfotransferase 1A1 polymorphism and gastric cancer risk: a pilot case-control study.
Boccia S; Persiani R; La Torre G; Rausei S; Arzani D; Gianfagna F; Romano-Spica V; D'Ugo D; Ricciardi G
Cancer Lett; 2005 Nov; 229(2):235-43. PubMed ID: 16137826
[TBL] [Abstract][Full Text] [Related]
10. SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
Tengström M; Mannermaa A; Kosma VM; Hirvonen A; Kataja V
BMC Cancer; 2012 Jun; 12():257. PubMed ID: 22708928
[TBL] [Abstract][Full Text] [Related]
11. Sulfotransferase 1A2*2 is a risk factor for early-onset breast cancer.
Hou MF; Chen ST; Chen JC; Yeh KT; Lee TP; Chen CM; Shih MC; Lin CC; Chang JG
Int J Mol Med; 2002 Nov; 10(5):609-12. PubMed ID: 12373301
[TBL] [Abstract][Full Text] [Related]
12. Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism.
Gjerde J; Hauglid M; Breilid H; Lundgren S; Varhaug JE; Kisanga ER; Mellgren G; Steen VM; Lien EA
Ann Oncol; 2008 Jan; 19(1):56-61. PubMed ID: 17947222
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Wolf G; Wascher TC; Paulweber B; Weitzer W; Samonigg H
Breast Cancer Res Treat; 2004 Sep; 87(1):19-22. PubMed ID: 15377847
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism in the sulfotransferase SULT1A1 gene in cancer.
Pereira WO; Paiva AS; Queiroz JW; Toma L; Dietrich CP; Nader HB; Jerônimo SM
Cancer Genet Cytogenet; 2005 Jul; 160(1):55-60. PubMed ID: 15949571
[TBL] [Abstract][Full Text] [Related]
15. Sulfotransferase1A1 and risk of postmenopausal breast cancer.
Jerevall PL; Ahmadi A; Bergman M; Stål O; Wingren S
Anticancer Res; 2005; 25(3c):2515-7. PubMed ID: 16080486
[TBL] [Abstract][Full Text] [Related]
16. [A case-control study on the association between the genetic polymorphism of sulfotransferase 1A1, diet and susceptibility of colorectal cancer].
Chen K; Fan CH; Jin MJ; Song L; Xu H; He HQ; Tong F
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):670-3. PubMed ID: 17274372
[TBL] [Abstract][Full Text] [Related]
17. Genotype-guided adjuvant endocrine therapy: new tricks from an old drug?
Peppercorn J; A Carey L
Expert Rev Anticancer Ther; 2008 Feb; 8(2):191-4. PubMed ID: 18279059
[TBL] [Abstract][Full Text] [Related]
18. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
19. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population.
Arslan S
Biochem Genet; 2010 Dec; 48(11-12):987-94. PubMed ID: 20936502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]